Filing Details
- Accession Number:
- 0001127602-25-013526
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-06 20:07:24
- Reporting Period:
- 2025-05-02
- Filing Date:
- 2025-05-06
- Accepted Time:
- 2025-05-06 20:07:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 318154 | Amgen Inc | AMGN | Biological Products, (No Disgnostic Substances) (2836) | 953540776 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1987926 | C. Matthew Busch | One Amgen Center Drive Thousand Oaks CA 91320 | Vp, Finance & Cao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-05-02 | 28 | $283.78 | 5,071 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2025-05-02 | 37 | $283.78 | 5,034 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2025-05-02 | 1,000 | $279.69 | 4,034 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- These shares include 93 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Billionaire Hedge Funds
